Niels W Boone

7PUBLICATIONS
6CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Additive manufacturingCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 18, 2026
Switching standard dosed intravenous to subcutaneous infliximab leads to similar drug exposure in inflammatory bowel disease patients independent of concomitant immunosuppressants (SHUFFLE study).

|Nov 13, 2025
Cost optimizing tocilizumab therapy in stable rheumatoid arthritis: a dose de-escalation nomogram to prevent overuse and unnecessary costs.

Kaja van Soest, Sofia Ramiro, Mirian J F Starmans-Kool

|Feb 15, 2023
Single dose tocilizumab for COVID-19 associated cytokine storm syndrome: Less is more.

Niels W Boone, Dirk Jan A R Moes, Sofia Ramiro

|Jan 08, 2020
Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.

Niels W Boone, Alexandre Sepriano, Paul-Hugo van der Kuy

|Feb 12, 2019
Cotreatment with methotrexate in routine care patients with rheumatoid arthritis receiving biological treatment yields better outcomes over time.

Niels W Boone, Alexandre Sepriano, Paul-Hugo van der Kuy

Pageof 2

Frequent Collaborators

2 joint publications

Alexandre Sepriano

1 joint publications

Kaja van Soest

1 joint publications

Sofia Ramiro

1 joint publications

Nieko C Punt